Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Over the last 12 months, insiders at Reneo Pharmaceuticals, Inc. have bought $639,578 and sold $98,058 worth of Reneo Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Reneo Pharmaceuticals, Inc. have bought $8.17M and sold $585,851 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Leonard Braden Michael (10 percent owner) — $3.84M.
The last purchase of 414,281 shares for transaction amount of $639,578 was made by Leonard Braden Michael (10 percent owner) on 2024‑05‑14.
2024-05-14 | Leonard Braden Michael | 10 percent owner | 414,281 1.1813% | $1.54 | $639,578 | +3.70% | ||
2023-08-28 | Sale | Hall Ashley | Chief Development Officer | 15,625 0.048% | $6.28 | $98,058 | -71.85% | |
2023-06-23 | Sale | Novo Holdings A/S | 10 percent owner | 100,000 0.4021% | $7.10 | $709,740 | -74.33% | |
2023-05-08 | O'Donnell Niall | director | 125,000 0.4267% | $8.00 | $1M | -32.69% | ||
2022-09-01 | Cruse Michael | Chief Operating Officer | 7,500 0.0297% | $3.39 | $25,448 | +23.29% | ||
2022-08-29 | Cruse Michael | Chief Operating Officer | 3,212 0.0129% | $3.21 | $10,307 | +30.37% | ||
2021-08-25 | FLESHER GREGORY J. | President and CEO | 8,000 0.0373% | $8.00 | $64,000 | -32.81% | ||
2021-08-25 | Jindal Vineet R. | Chief Financial Officer | 5,000 0.0216% | $7.44 | $37,177 | -32.81% | ||
2021-08-25 | Cruse Michael | Senior VP-Corporate Operations | 2,500 0.0108% | $7.45 | $18,616 | -32.81% | ||
2021-07-14 | Sale | Johnson Wendy S. | Chief Development Officer | 111,736 0.4501% | $8.50 | $949,756 | -25.14% | |
2021-07-14 | Muralidhar Bali | director | 111,736 0.4501% | $8.50 | $949,756 | -25.14% | ||
2021-06-23 | Muralidhar Bali | director | 20,710 0.0938% | $9.28 | $192,245 | -28.36% | ||
2021-06-22 | Muralidhar Bali | director | 14,615 0.0653% | $8.72 | $127,487 | -24.78% | ||
2021-06-21 | Muralidhar Bali | director | 32,659 0.159% | $9.03 | $294,927 | -20.74% | ||
2021-06-08 | Muralidhar Bali | director | 16,605 0.0767% | $9.50 | $157,709 | -27.00% | ||
2021-06-04 | Muralidhar Bali | director | 257 0.0012% | $9.42 | $2,422 | -26.44% | ||
2021-06-03 | Muralidhar Bali | director | 12,100 0.0568% | $9.25 | $111,943 | -22.32% | ||
2021-05-28 | Muralidhar Bali | director | 14 <0.0001% | $9.50 | $133 | -27.26% | ||
2021-05-27 | Muralidhar Bali | director | 1,120 0.005% | $9.26 | $10,369 | -23.50% | ||
2021-05-26 | Muralidhar Bali | director | 5,915 0.0276% | $9.38 | $55,495 | -21.47% |
Leonard Braden Michael | 10 percent owner | 2672194 7.9956% | $1.57 | 1 | 0 | |
Hall Ashley | Chief Development Officer | 39600 0.1189% | $1.57 | 0 | 1 | |
New Enterprise Associates 15, L.P. | 10 percent owner | 4785494 14.3658% | $1.57 | 1 | 0 | <0.0001% |
Novo Holdings A/S | 10 percent owner | 3330337 9.9975% | $1.57 | 1 | 1 | <0.0001% |
RiverVest Venture Fund III, L.P. | 10 percent owner | 2409220 7.2323% | $1.57 | 1 | 0 | <0.0001% |
O'Donnell Niall | director | 2188713 6.5704% | $1.57 | 2 | 0 | <0.0001% |
Muralidhar Bali | director | 2073957 6.2259% | $1.57 | 11 | 0 | <0.0001% |
Cruse Michael | Chief Operating Officer | 13697 0.0411% | $1.57 | 3 | 0 | +6.95% |
FLESHER GREGORY J. | President and CEO | 8000 0.024% | $1.57 | 1 | 0 | <0.0001% |
Jindal Vineet R. | Chief Financial Officer | 5000 0.015% | $1.57 | 1 | 0 | <0.0001% |
Johnson Wendy S. | Chief Development Officer | 0 0% | $1.57 | 0 | 1 |
Nea Management Company Llc | $7.94M | 14.32 | 4.79M | 0% | +$0 | 0.09 | |
Tang Capital Management, LLC | $4.98M | 8.97 | 3M | -10% | -$552,780.00 | 0.02 | |
Highbridge Capital Management | $4.54M | 8.19 | 2.74M | +143.97% | +$2.68M | 0.13 | |
The Carlyle Group | $4.45M | 8.08 | 2.7M | 0% | +$0 | 0.19 | |
RiverVest | $4.21M | 7.58 | 2.53M | 0% | +$0 | 51.67 | |
Octagon Capital Advisors LP | $3.73M | 6.73 | 2.25M | 0% | +$0 | 0.49 | |
Bml Capital Management Llc | $3.62M | 6.52 | 2.18M | +65.72% | +$1.43M | 2.75 | |
BlackRock | $1.65M | 2.97 | 993,659 | +1.05% | +$17,189.29 | <0.0001 | |
The Vanguard Group | $1.61M | 2.91 | 970,796 | -0.83% | -$13,434.38 | <0.0001 | |
Aisling Capital Management LP | $1.47M | 2.65 | 886,075 | 0% | +$0 | 0.5 | |
ROCK SPRINGS CAPITAL MANAGEMENT, LP | $1.25M | 2.25 | 751,730 | 0% | +$0 | 0.03 | |
Renaissance Technologies | $985,000.00 | 1.78 | 593,295 | +48.18% | +$320,248.06 | <0.01 | |
Acuitas Investments, LLC | $670,720.00 | 1.21 | 404,048 | New | +$670,720.00 | 0.35 | |
Aldebaran Capital Llc | $658,041.00 | 1.19 | 396,410 | New | +$658,041.00 | 0.63 | |
Geode Capital Management | $552,363.00 | 1 | 332,703 | -2.01% | -$11,352.64 | <0.0001 | |
State Street | $410,734.00 | 0.74 | 247,430 | 0% | +$0 | <0.0001 | |
Morgan Stanley | $377,085.00 | 0.68 | 227,159 | +81.84% | +$169,708.92 | <0.0001 | |
Bank of Montreal | $227,854.00 | 0.4 | 134,032 | New | +$227,854.00 | <0.0001 | |
Two Sigma | $216,778.00 | 0.39 | 130,589 | -28.43% | -$86,129.20 | <0.0001 | |
Northern Trust | $186,157.00 | 0.34 | 112,143 | -3.85% | -$7,465.01 | <0.0001 | |
Gsa Capital Partners Llp | $146,000.00 | 0.26 | 88,020 | -7.22% | -$11,365.51 | 0.01 | |
Jbf Capital Inc | $132,800.00 | 0.24 | 80,000 | 0% | +$0 | 0.02 | |
Tealwood Asset Management | $122,459.00 | 0.22 | 73,770 | New | +$122,459.00 | 0.03 | |
Citadel Advisors LLC | $109,801.00 | 0.2 | 66,145 | +584.16% | +$93,752.08 | <0.0001 | |
Goldman Sachs | $64,327.00 | 0.12 | 38,751 | -40.19% | -$43,218.33 | <0.0001 | |
Charles Schwab | $62,255.00 | 0.11 | 37,503 | 0% | +$0 | <0.0001 | |
BNY Mellon | $56,815.00 | 0.1 | 34,227 | -22.21% | -$16,217.68 | <0.0001 | |
Fifth Lane Capital Lp | $54,174.00 | 0.1 | 32,635 | -18.41% | -$12,225.88 | 0.01 | |
Alps Advisors Inc | $39,003.00 | 0.07 | 23,496 | +1.6% | +$614.19 | <0.0001 | |
Css Llc Il | $33,678.00 | 0.06 | 20,288 | 0% | +$0 | <0.01 | |
American Century Investments | $30,255.00 | 0.06 | 18,226 | 0% | +$0 | <0.0001 | |
Nuveen | $29,948.00 | 0.05 | 18,041 | 0% | +$0 | <0.0001 | |
Prelude Capital | $28,590.00 | 0.05 | 17,223 | New | +$28,590.00 | <0.01 | |
Two Sigma Advisers LP | $26,892.00 | 0.05 | 16,200 | New | +$26,892.00 | <0.0001 | |
JPMorgan Chase | $24,973.00 | 0.05 | 15,044 | -7% | -$1,879.12 | <0.0001 | |
Dimensional Fund Advisors | $22,122.00 | 0.04 | 13,327 | 0% | +$0 | <0.0001 | |
UBS | $19,713.00 | 0.04 | 11,875 | -27.81% | -$7,593.03 | <0.0001 | |
RhumbLine Advisers | $18,206.00 | 0.03 | 10,972 | +3.61% | +$633.86 | <0.0001 | |
Susquehanna International Group | $17,787.00 | 0.03 | 10,715 | -35.24% | -$9,681.17 | <0.0001 | |
Tower Research Capital | $15,733.00 | 0.03 | 9,478 | +39.9% | +$4,486.84 | <0.0001 | |
Barclays | $13,000.00 | 0.02 | 8,158 | -66.61% | -$25,937.85 | <0.0001 | |
Group One Trading | $12,601.00 | 0.02 | 7,591 | New | +$12,601.00 | <0.0001 | |
American International Group | $10,508.00 | 0.02 | 6,330 | -1.86% | -$199.20 | <0.0001 | |
China Universal Asset Management Co., Ltd. | $10,604.00 | 0.02 | 6,388 | +65.66% | +$4,203.09 | <0.01 | |
Citigroup | $10,020.00 | 0.02 | 6,036 | +115.8% | +$5,376.87 | <0.0001 | |
Wells Fargo | $8,836.00 | 0.02 | 5,323 | +10.48% | +$838.28 | <0.0001 | |
Bank of America | $7,259.00 | 0.01 | 4,373 | -81.76% | -$32,545.15 | <0.0001 | |
Fidelity Investments | $2,664.00 | 0.01 | 1,605 | +796.65% | +$2,366.89 | <0.0001 | |
CalSTRS | $2,420.00 | <0.01 | 1,458 | -31.74% | -$1,125.35 | <0.0001 | |
Legal & General | $2,354.00 | <0.01 | 1,418 | 0% | +$0 | <0.0001 |